## Abstract This commentary highlights the promising results of recent studies in animal models of Duchenne muscular dystrophy and amyotrophic lateral sclerosis that have clearly demonstrated the potential of gene therapy for tackling these diseases. In the absence of effective drugs or other treat
Progress in gene therapy for Duchenne muscular dystrophy
β Scribed by Paula R. Clemens; F Jason Duncan
- Book ID
- 107543113
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 396 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1528-4042
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Mutations in the dystrophin gene cause an Xβlinked genetic disorder: Duchenne muscular dystrophy (DMD). Stem cell therapy is an attractive method to treat DMD because a small number of cells are required to obtain a therapeutic effect. Here, we discussed about multiple types of myogenic
Duchenne muscular dystrophy (DMD) is a fatal disorder affecting approximately 1 in 3500 live born males, characterized by progressive muscle weakness. Several different strategies are being investigated in developing a cure for this disorder. Until a cure is found, therapeutic and supportive care is